Office of New Drugs (OND)

The Office of New Drugs (OND) is a division within the FDA responsible for overseeing the development and approval of new medications. It reviews clinical trial data to ensure that new drugs are safe and effective for public use. The OND works closely with pharmaceutical companies throughout the drug development process, from early research to final approval. Its goal is to facilitate access to innovative medicines while maintaining high standards for safety and quality, ultimately protecting and promoting public health.